ECOR (ECOR) Stock Price & Analysis
ECOR (ECOR) fell 1.30% to USD 9.09 as of September 8, 2026 at 16:11 UTC, according to Nexqual real-time market data.
ECOR last closed at USD 9.09; the session ranged USD 8.87–9.14 on volume of 8,189 shares. Market capitalization is —, with a 52-week range of USD 4.41–10.95 (NCM). Source: Nexqual, September 8, 2026 at 16:11 UTC.
Key Statistics (as of September 8, 2026 at 16:11 UTC)
| Price | USD 9.09 |
|---|---|
| Change | ▼ 1.30% (down) |
| Previous Close | USD 9.09 |
| Open | USD 9.09 |
| Day Range | USD 8.87 – 9.14 |
| 52-Week Range | USD 4.41 – 10.95 |
| Volume | 8,189 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ECOR)
Nexqual's technical model rates ECOR "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 16:11 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.55 (neutral) |
| vs SMA50 | Above (USD 7.99) |
| MACD | 0.35 (positive) |
From ECOR's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRPO | Precipio, Inc. | USD 26.69 | ▲ 2.18% |
| ATHE | Alterity Therapeutics Limited | USD 4.5 | ▼ 0.44% |
| TTOO | T2 Biosystems, Inc. | USD 0 | ▲ 0% |
| DARE | Dare Bioscience, Inc. | USD 0.72 | ▲ 0.28% |
| COCP | Cocrystal Pharma, Inc. | USD 1.19 | ▲ 4.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:11 UTC. This page is informational and not investment advice.